Related Experiment Video
Updated: Aug 23, 2025

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
Published on: November 9, 2018
Microfluidic Chamber Technology to Study Missorting and Spreading of Tau Protein in Alzheimer's Disease
Senthilvelrajan Kaniyappan1, Varun Balaji2,3, Yipeng Wang2,4
1DZNE, German Center for Neurodegenerative Diseases, Bonn, Germany. senthil.kaniyappan@dzne.de.
Abstract:
Tau is a microtubule-associated protein found mainly in the axons of neurons in the brain. Abnormal changes in Tau (e.g., aggregation, hyperphosphorylation) are hallmarks of Alzheimer's disease. Two processes of relocalization of Tau may be related to early states of the pathology and have received much attention: (1) the redistribution of Tau within cells (termed "somatodendritic missorting") and (2) the release and reuptake of Tau from donor to acceptor cells (termed "spreading"). Because of the tripartite nature of neurons (cell body, dendrites, axons), these changes can be studied by microfluidic chambers (MFCs) which allow separation and observation of Tau in neuronal compartments. In this chapter, we present some methods and research results obtained by using microfluidic devices.

